abrdn Healthcare Investors (abrdn Healthcare Investors) Enterprise Value : $849.48 Mil (As of May. 06, 2024)

View and export this data going back to . Start your Free Trial

What is abrdn Healthcare Investors Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. This ratio does not apply to banks.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. This ratio does not apply to banks.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, abrdn Healthcare Investors's Enterprise Value is $849.48 Mil. abrdn Healthcare Investors's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $58.12 Mil. Therefore, abrdn Healthcare Investors's EV-to-Revenue ratio for today is 14.62.

abrdn Healthcare Investors Enterprise Value Historical Data

The historical data trend for abrdn Healthcare Investors's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

abrdn Healthcare Investors Enterprise Value Chart

abrdn Healthcare Investors Annual Data

Trend

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Enterprise Value

Get a 7-Day Free Trial

783.78

904.63

1,161.53

818.10

768.82

abrdn Healthcare Investors Semi-Annual Data
	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Enterprise Value	Get a 7-Day Free Trial								1,161.53	962.56	818.10	853.40	768.82

Competitive Comparison of abrdn Healthcare Investors's Enterprise Value

For the Asset Management subindustry, abrdn Healthcare Investors's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

abrdn Healthcare Investors's Enterprise Value Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, abrdn Healthcare Investors's Enterprise Value distribution charts can be found below:

* The bar in red indicates where abrdn Healthcare Investors's Enterprise Value falls into.

abrdn Healthcare Investors Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

abrdn Healthcare Investors's Enterprise Value for the fiscal year that ended in Sep. 2023 is calculated as

	Enterprise Value (A: Sep. 2023 )
=	Market Cap	+	Preferred Stock	+	Long-Term Debt & Capital Lease Obligation
=	768.8231	+	0	+	0
+	Short-Term Debt & Capital Lease Obligation	+	Minority Interest	-	Balance Sheet Cash And Cash Equivalents
+	0	+	0	-	0
=	768.82

abrdn Healthcare Investors's Enterprise Value for the quarter that ended in Sep. 2023 is calculated as

	Enterprise Value (Q: Sep. 2023 )
=	Market Cap	+	Preferred Stock	+	Long-Term Debt & Capital Lease Obligation
=	768.8231	+	0	+	0
+	Short-Term Debt & Capital Lease Obligation	+	Minority Interest	-	Balance Sheet Cash And Cash Equivalents
+	0	+	0	-	0
=	768.82

abrdn Healthcare Investors (NYSE:HQH) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

abrdn Healthcare Investors's EV-to-Revenue for today is:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	849.484	/	58.118
	=	14.62

abrdn Healthcare Investors's current Enterprise Value is $849.48 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. abrdn Healthcare Investors's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $58.12 Mil.

abrdn Healthcare Investors Enterprise Value Related Terms

Thank you for viewing the detailed overview of abrdn Healthcare Investors's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.

abrdn Healthcare Investors (abrdn Healthcare Investors) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » abrdn Healthcare Investors (NYSE:HQH) » Definitions » Enterprise Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

900 Market Street, Suite 200, Philadelphia, PA, USA, 19103

Website

https://www.teklacap.com

abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.

Executives

Todd Reit	director	C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Bill Maher	director	600 WEST BROADWAY, 30TH FL., SAN DIEGO CA 92101
Alan R Goodson	officer: Vice President	1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Rose Dimartino	director	C/O ABRDN, 1900 MARKET STREET, PHILADELPHIA PA 19103
James Joseph O'connor	other: Director of Adviser	C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Marika Tooze	other: Director of Adviser	C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Aberdeen Standard Investments Inc.	other: Adviser	1900 MARKET ST., 2ND FLOOR, PHILADELPHIA PA 19103
Jaclyn Marie Matsick	other: Director of Adviser	C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Lucia Sitar	officer: VP and Chief Legal Officer	1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Jennifer A Nichols	other: Director of Adviser	1735 MARKET STREET, 37TH FLOOR, PHILADELPHIA PA 19103
Christian Pittard	officer: President	ONE BOW CHURCHYARD, LONDON X0 EC4M 9HH
Megan Kennedy	officer: Secretary and Vice President	1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Sharon Ferrari	officer: Treasurer and CFO	1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Joseph Andolina	officer: Chief Compliance Officer & VP	1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Stephen Bird	director	388 GREENWICH STREET, 17TH FLOOR, NEW YORK NY 10022